← Every company

Anavex Life Sciences Corp SEC Filings

What Anavex Life Sciences Corp has told the SEC happened, by the 8-K items and forms it filed under: when it reported results, who joined or left, what it bought or sold, and whether its auditor or its accounts ever changed.

AVXL overview →
Filings on file
79
since Dec 14, 2016
Warning signs
4
latest Aug 10, 2026
Last results
Aug 25, 2026
8-K item 2.02
Industry
Biological Products, (No Diagnostic Substances)
SIC 2836

Newest first

Each label is a form type or an 8-K item as filed; each row links to the filing.

FiledWhat it reportsDocument
Aug 10, 2026
Late filing notice
NT 10-Q
Read ↗
May 22, 2026
Delisting notice or listing transfer
8-K
Read ↗
May 11, 2026
Late filing notice
NT 10-Q
Read ↗
Mar 4, 2022
Auditor changeExecutive or director change
8-K
Read ↗

Source: Anavex Life Sciences Corp's EDGAR filing history, the last ten years. The labels are the form types and 8-K item numbers the company filed under, not a reading of what it wrote — an item 5.02 can be a chief executive fired or a director retiring on schedule — so each row links to the filing.

More on AVXL

Related datasets